Showing results (1861-1870 of 3,014) with videos related to
Sort By:
Pageof 302
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 29, 2007
Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancerRichard Pötter, Johannes Dimopoulos, Petra Georg, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 26, 2009
Effects of escitalopram on stress-related relapses in women with multiple sclerosis: an open-label, randomized, controlled, one-year follow-up studyCharalampos I Mitsonis, Iannis M Zervas, Constantin M Potagas, et al.Journal of Hematology & Oncology|June 1, 2021
Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitorsEvangelos Terpos, Flora Zagouri, Michalis Liontos, et al.Diagnostics (Basel, Switzerland)|March 29, 2023
Upraising Stenotrophomonas maltophilia in Critically Ill Patients: A New Enemy?George Dimopoulos, José Garnacho-Montero, Elisabeth Paramythiotou, et al.International Journal of Cancer|October 11, 2008
Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implicationEfstathios Kastritis, Samuel Murray, Fani Kyriakou, et al.World Journal of Clinical Cases|June 29, 2023
Incidence and peri-operative risk factors for development of acute kidney injury in patients after cardiac surgery: A prospective observational studyStavros Dimopoulos, Georgios Zagkotsis, Charalambia Kinti, et al.Blood Cancer Journal|March 11, 2020
Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysisMeletios A Dimopoulos, Ruben Niesvizky, Katja Weisel, et al.Leukemia & Lymphoma|May 14, 2016
Relationship of response and survival in patients with relapsed and refractory multiple myeloma treated with pomalidomide plus low-dose dexamethasone in the MM-003 trial randomized phase III trial (NIMBUS)Philippe Moreau, Katja C Weisel, Kevin W Song, et al.Leukemia & Lymphoma|February 27, 2016
Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myelomaFlora Zagouri, Maria Roussou, Efstathios Kastritis, et al.Current Pharmaceutical Biotechnology|April 19, 2018
Harvesting, Isolation and Differentiation of Rat Adipose-Derived Stem CellsPanayiotis D Megaloikonomos, Georgios N Panagopoulos, Myrto Bami, et al.Pageof 302